Halisyo badan oo fayras neef-mareenka ah xilliga jiilaalka
Tallaabooyinka lagu yareynayo gudbinta SARS-CoV-2 ayaa sidoo kale waxtar u leh yareynta gudbinta fayrasyada kale ee neef-mareenka ee faafa. Maadaama dalal badan ay yareeyaan isticmaalka tallaabooyinka noocaas ah, SARS-CoV-2 wuxuu la wareegi doonaa fayrasyada kale ee neefsashada, taasoo kordhinaysa suurtagalnimada caabuqyada wadajirka ah.
Khubaradu waxay saadaalinayaan in jiilaalku uu jiri karo cudur faafa oo saddex-jibbaaran sababtoo ah isku-darka heerka ugu sarreeya ee hargabka (Durayga) iyo fayraska neef-mareenka (RSV) oo ay weheliso cudurka faafa ee SARS-CoV-2. Tirada kiisaska hargabka iyo RSV sanadkan ayaa durba ka sarreeya tii isla muddadaas sannadihii hore. Noocyada cusub ee BA.4 iyo BA.5 ee fayraska SARS-CoV-2 ayaa mar kale sii xumeeyay cudurka faafa.
Shir-madaxeedka "Maalinta Duufaanta Adduunka 2022" ee Noofambar 1, 2022, Zhong Nanshan, oo ah aqoonyahan ka tirsan Akadeemiyada Injineerinka Shiinaha, ayaa si qoto dheer u falanqeeyay xaaladda hargabka ee gudaha iyo dibadda, wuxuuna sameeyay cilmi-baaristii ugu dambeysay iyo go'aan ku saabsan xaaladda hadda jirta."Adduunku wali wuxuu wajahayaa khatarta cudurrada faafa ee faafa ee fayraska SARS-CoV-2 iyo cudurka faafa ee hargabka." ayuu tilmaamay, "Gaar ahaan jiilaalkan, wali waxay u baahan tahay in la xoojiyo cilmi-baarista ku saabsan arrimaha sayniska ee ka hortagga iyo xakamaynta hargabka."Sida laga soo xigtay tirakoobka US CDC, tirada booqashooyinka isbitaallada ee loogu talagalay caabuqyada neefsashada ee Mareykanka ayaa si weyn u kordhay sababtoo ah isku-darka hargabka iyo caabuqyada cusub ee wadnaha.
Kordhinta ogaanshaha RSV iyo booqashooyinka waaxda gurmadka degdegga ah ee la xiriirta RSV iyo isbitaallada la dhigo gobollo badan oo Mareykanka ah, iyadoo gobollada qaar ay ku dhow yihiin heerarka ugu sarreeya xilliyeedka. Waqtigan xaadirka ah, tirada kiisaska caabuqa RSV ee Mareykanka ayaa gaartay meeshii ugu sarreysay muddo 25 sano ah, taasoo keentay in isbitaallada carruurta ay buux dhaafaan, qaar ka mid ah dugsiyadana la xiro.
Cudurka faafa ee hargabka ayaa ka dilaacay Australia bishii Abriil ee sanadkan wuxuuna socday ku dhawaad 4 bilood. Laga bilaabo Sebtembar 25, waxaa jiray 224,565 kiis oo hargabka ah oo shaybaarku xaqiijiyay, taasoo keentay 305 dhimasho oo la xiriira. Taas bedelkeeda, iyadoo la raacayo tallaabooyinka ka hortagga faafitaanka fayraska SARS-CoV-2, waxaa jiri doona qiyaastii 21,000 oo kiis oo hargabka ah oo ka dhaca Australia sanadka 2020 iyo wax ka yar 1,000 sanadka 2021.
Warbixintii toddobaadlaha ahayd ee 35-aad ee Xarunta Hargabka Shiinaha sannadkii 2022 ayaa muujinaysa in saamiga kiisaska hargabka ee gobollada waqooyi uu ka sarreeyay heerka isla muddadaas 2019-2021 muddo 4 toddobaad oo xiriir ah, xaaladda mustaqbalkana ay aad u sii xumaan doonto. Laga bilaabo bartamihii Juun, tirada kiisaska hargabka u eg ee laga soo sheegay Guangzhou ayaa korodhay 10.38 jeer marka la barbar dhigo sannadkii hore.
Natiijooyinka daraasad lagu sameeyay 11 waddan oo ay soo saartay The Lancet Global Health bishii Oktoobar ayaa muujisay in u nuglaanshaha dadka hadda jira ee hargabka uu kordhay ilaa 60% marka la barbar dhigo ka hor cudurka faafa. Waxay sidoo kale saadaalisay in baaxadda ugu sarreysa ee xilliga hargabka 2022 ay kordhi doonto 1-5 jeer, cabbirka cudurka faafana uu kordhi doono ilaa 1-4 jeer.
212,466 qof oo qaangaar ah oo qaba cudurka SARS-CoV-2 kuwaas oo la dhigay isbitaalka. Baaritaanno lagu sameeyay caabuqyada fayraska neefsashada ayaa lagu diiwaangeliyay 6,965 bukaan oo qaba SARS-CoV-2. Cudurka fayraska ee wadajirka ah ayaa lagu ogaaday 583 bukaan (8·4%): 227 bukaan ayaa qabay fayrasyada hargabka, 220 bukaan ayaa qabay fayrasyada neefsashada ee isku-dhafan, iyo 136 bukaan ayaa qabay fayrasyada adenovirus.
Caabuqa fayraska hargabka waxaa lala xiriiriyay fursadaha sii kordhaya ee helitaanka hawo-qaadis farsamo oo duullaan ah marka la barbar dhigo SARS-CoV-2 mono-infection. Caabuqa SARS-CoV-2 ee fayraska hargabka iyo adenoviruses mid walba wuxuu si weyn ula xiriiray fursadaha dhimashada oo kordhay. OR ee hawo-qaadis farsamo oo duullaan ah ee caabuqa hargabka ee isku-darka ah wuxuu ahaa 4.14 (95% CI 2.00-8.49, p=0.0001). OR ee dhimashada isbitaalka ee bukaanada isku-darka ah ee hargabka waxay ahayd 2.35 (95% CI 1.07-5.12, p=0.031). OR ee dhimashada isbitaalka ee bukaanada isku-darka ah ee adenovirus wuxuu ahaa 1.6 (95% CI 1.03-2.44, p=0.033).
Natiijooyinka daraasaddan waxay si cad noo sheegayaan in isku-darka fayraska SARS-CoV-2 iyo fayraska hargabka ay tahay xaalad khatar gaar ah leh.
Kahor inta uusan dillaacin SARS-CoV-2, calaamadaha fayrasyada neef-mareenka ee kala duwan aad bay isugu ekaayeen, laakiin hababka daaweyntu way kala duwanaayeen. Haddii bukaannadu aysan ku tiirsanaan baaritaanno badan, daaweynta fayrasyada neef-mareenka ayaa sii adkaan doonta, waxayna si fudud u lumin doontaa kheyraadka isbitaalka inta lagu jiro xilliyada dhacdooyinka badan. Sidaa darteed, baaritaanno badan oo kala-goysyada ah ayaa door muhiim ah ka ciyaara ogaanshaha caafimaad, dhakhaatiirtuna waxay awoodaan inay bixiyaan baaritaanno kala duwan oo ku saabsan jeermiska ku dhaca bukaanada qaba calaamadaha neefsashada iyagoo isticmaalaya hal muunad oo suuf ah.
Xalalka Baaritaanka Kala-goysyada Badan ee Neefsashada ee SARS-CoV-2 ee Macro & Micro-Test
Macro & Micro-Test waxay leedahay goobo farsamo sida PCR-ka fluorescent quantitative, kordhinta kuleylka isothermal-ka, tallaalka, iyo POCT-ga molecular-ka, waxayna bixisaa noocyo kala duwan oo ah badeecooyinka ogaanshaha kala-goysyada neefsashada ee SARS-CoV-2. Dhammaan badeecooyinka waxay heleen shahaadada EU CE, iyadoo leh waxqabad badeecadeed oo heer sare ah iyo khibrad isticmaale oo wanaagsan.
1. Qalabka RT-PCR ee waqtiga-dhabta ah ee fluorescent-ka ah si loo ogaado lix nooc oo ah jeermisyada neefsashada
Xakamaynta Gudaha: Si buuxda ula soco habka tijaabada si loo hubiyo tayada tijaabooyinka.
Waxtar Sare: Multiplex PCR-ka waqtiga-dhabta ah wuxuu ogaadaa bartilmaameedyo kala duwan oo gaar ah oo loogu talagalay SARS-CoV-2, Hargabka A, Hargabka B, Adenovirus, Mycoplasma pneumoniae, iyo fayraska isku-dhafka neefsashada.
Xasaasiyadda sare: 300 Nuqul/mL SARS-CoV-2, 500 Nuqul/mL fayraska hargabka A, 500 Nuqul/mL fayraska hargabka B, 500 Nuqul/mL fayraska isku-dhafka neefsashada, 500 Nuqul/mL ee pneumoniae mycoplasma, iyo 500 Nuqul/mL ee adenovirus.
2. Qalabka Baaritaanka Isku-dhafan ee SARS-CoV-2/Hargabka A /Hargabka B ee Nucleic Acid (Fluorescence PCR)
Xakamaynta Gudaha: Si buuxda ula soco habka tijaabada si loo hubiyo tayada tijaabooyinka.
Waxtar Sare: Multiplex PCR-ka waqtiga-dhabta ah wuxuu ogaadaa bartilmaameedyo kala duwan oo gaar ah oo loogu talagalay SARS-CoV-2, Hargabka A iyo Hargabka B.
Xasaasiyadda sare: 300 Nuqullo/mL oo SARS-CoV-2,500 Nuqullo/mL oo lFV A ah iyo 500 Nuqullo/mL oo lFV B ah.
3. Qalabka Baaritaanka Antigen-ka ee SARS-CoV-2, Hargabka A iyo Influenza B (Immunochromatography)
Si Fudud Loo Isticmaalo
Heerkulka Qolka Gaadiidka & kaydinta 4-30°℃
Xasaasiyadda sare iyo gaar ahaanshaha
| Magaca Badeecada | Faahfaahinta |
| Qalabka RT-PCR ee waqtiga-dhabta ah ee fluorescent-ka ah si loo ogaado lix nooc oo cudurro neef-mareenka ah | 20 tijaabo/xirmo,48 tijaabo/xirmo,50 tijaabo/qalab |
| Qalabka Baaritaanka Isku-dhafan ee SARS-CoV-2/Hargabka A /Hargabka B ee Nucleic Acid (Fluorescence PCR) | 48 tijaabo/xirmo,50 tijaabo/qalab |
| Qalabka Baaritaanka Antigen-ka ee SARS-CoV-2, Hargabka A iyo Hargabka B (Immunochromatography) | 1 qalab tijaabo/xirmo,20 tijaabo/xirmo |
Waqtiga boostada: Diseembar-09-2022